Turgut F, Yaprak M, Abdel-Rahman E. Management of hypertension: Current state of the art and challenges. World J Hypertens 2016; 6(1): 53-59 [DOI: 10.5494/wjh.v6.i1.53]
Corresponding Author of This Article
Emaad Abdel-Rahman, MD, PhD, FASN, Professor of Internal Medicine and Nephrology, Division of Nephrology, Department of Medicine, University of Virginia Health System, Box 800133, Charlottesville, VA 22908, United States. ea6n@virginia.edu
Research Domain of This Article
Allergy
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hypertens. Feb 23, 2016; 6(1): 53-59 Published online Feb 23, 2016. doi: 10.5494/wjh.v6.i1.53
Management of hypertension: Current state of the art and challenges
Faruk Turgut, Mustafa Yaprak, Emaad Abdel-Rahman
Faruk Turgut, Mustafa Yaprak, Department of Nephrology, School of Medicine, Mustafa Kemal University, 31034 Hatay, Turkey
Emaad Abdel-Rahman, Division of Nephrology, Department of Medicine, University of Virginia Health System, Box 800133, Charlottesville, VA 22908, United States
Author contributions: Turgut F and Yaprak M wrote the manuscript; Abdel-Rahman E edited the manuscript.
Conflict-of-interest statement: The authors declare that they no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Emaad Abdel-Rahman, MD, PhD, FASN, Professor of Internal Medicine and Nephrology, Division of Nephrology, Department of Medicine, University of Virginia Health System, Box 800133, Charlottesville, VA 22908, United States. ea6n@virginia.edu
Telephone: +1-434-2432671 Fax: +1-434-9245848
Received: September 30, 2015 Peer-review started: October 8, 2015 First decision: November 30, 2015 Revised: December 4, 2015 Accepted: January 16, 2016 Article in press: January 18, 2016 Published online: February 23, 2016 Processing time: 146 Days and 8.4 Hours
Abstract
Hypertension is a major modifiable cardiovascular risk factor. Hypertension is also recognized as the most important risk factor for global disease burden. It is well established that a sustained reduction in blood pressure by drugs reduces the incidence of cardiovascular morbidity and mortality. In recent years, studies and new guidelines published for the management of hypertension. Awareness, treatment and control of hypertension are very poor, despite the new guidelines. We highlighted the management of hypertension in the light of current literature.
Core tip: Hypertension is a major modifiable cardiovascular risk factor. It is well established that a sustained reduction in blood pressure by drugs reduces the incidence of cardiovascular morbidity and mortality. There are several types of drugs that can be used in the management of hypertension. But, the ideal treatment strategy remains uncertain for such a common and treatable disease. In recent years, studies and new guidelines were published addressing management of hypertension. Despite new guidelines, awareness, treatment and control of hypertension are very poor. We highlighted the management of hypertension in the light of current literature.
